Nixen has sold its stake in French veterinary laboratory Ceva Santé Animale as part of the company’s management buyout, which sees Sagard and Euromezzanine reinvest alongside new backers.
Deal is the second investment for Elysian Capital III, which closed on its GBP 325m hard-cap in 2020
Sale still requires approval from the league's executive committee and clubs
New BVCA chair discusses her priorities for the year ahead, the buoyant environment for venture, how to improve PE's public image, and more
Deal also includes an irrevocable option to sell certain juice businesses in Europe